Biotechnology professional with over 15 years of US and Global oncology/hematology experience: provided commercial assessment on numerous in-licensing opportunities, led the successful global launch of a targeted therapy in a major solid tumor and as a Global Commercial Lead, advanced numerous oncology Phase I/II compounds into Phase III registrational trials.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences